Vivian Eisfeller

BioNTech SE is a biotechnology company that develops and manufactures innovative immunotherapies and vaccines for the prevention and treatment of diseases. It uses its proprietary mRNA-based platform to develop individualized therapies for cancer and other serious diseases.

BioNTech SE

biontech_se

Free Corporate Rating

• SB2A Temperature Range: 1.5°C < SB2A ≤ 2°C
• Description: These companies, while not in the top tier of priority enablers, still play a crucial role in advancing climate goals. Their activities align within the 1.5 to 2-degree temperature range, signifying a substantial contribution to mitigating climate change.

● SB2A temperature range: 3°C ≤ SB2A < 4°C
● Description: Engaging companies face a critical need for environmental improvement as their carbon intensity is increasing. With SB2A indicating a substantial temperature misalignment (3°C ≤ SB2A < 4°C), these companies are recognized as having a high environmental impact. Engaging companies are urged to prioritize and accelerate their sustainability initiatives to address their significant climate-related challenges.

• SB2A Temperature Range: SB2A ≤ 1.5°C
• Description: Companies falling into this category demonstrate an exceptional commitment to climate alignment. Their activities contribute significantly to maintaining global warming well below the 2-degree target, positioning them as leaders in enabling a sustainable future.

● SB2A temperature range: ≥ 4°C
● Description: Priority Engaging companies face a critical need for environmental improvement. With SB2A indicating a substantial temperature misalignment (≥ 4°C), these companies are recognized as having a very high environmental impact. Priority Engaging companies are urged to prioritize and accelerate their sustainability initiatives to address their significant climate-related challenges.

• SB2A Temperature Range: 2°C ≤ SB2A < 3°C
• Description: Companies in this category are strategically positioning themselves for a sustainable transition. Their commitment is evident through an decrease in carbon intensity at company level together with certified targeted plan for further reduction and a decrease in temperature.

• SB2A Temperature Range: 2°C ≤ SB2A < 3°C
• Description: Transitioning companies are actively engaged in reducing their carbon footprint. The decrease in the carbon intensity at company level is the sign that these entities are making strides toward sustainability, even if a specific reduction target is yet to be formalized.

Rating peers in sector of {{sector}} (based on {{total}} companies)

Discover other companies in {{sector}} with {{score}} score

Climate Rating: Priority Transitioning - BioNTech SE is a biotechnology company that develops and manufactures innovative immunotherapies and vaccines for the prevention and treatment of diseases. It uses its proprietary mRNA-based platform to develop individualized therapies for cancer and other serious diseases.

Free Corporate Rating

BioNTech SE

ISIN

LEI

Description

Rating peers in sector of Health Care (based on 265 companies)

9%

Leader

9%

Aligné

5%

En
transition
active

27%

En
transition

40%

Non
aligné

10%

Faibles

Discover other companies in Health Care with En transition active score

Get in touch!

Free Corporate Rating

BioNTech SE

ISIN

LEI

Description

Rating peers in sector of Health Care (based on 265 companies)

9%

Leader

9%

Aligné

5%

Entransitionactive

27%

Entransition

40%

Nonaligné

10%

Faibles

Discover other companies in Health Care with En transition active score

Get in touch!

En
transition
active

En
transition

Non
aligné